International Journal For Multidisciplinary Research
E-ISSN: 2582-2160
•
Impact Factor: 9.24
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with IJFMR
Upcoming Conference(s) ↓
Conferences Published ↓
DePaul-2026
IC-AIRCM-T3-2026
NSSFIGTMA-2025
SPHERE-2025
AIMAR-2025
SVGASCA-2025
ICRTET-4
ICCE-2025
Chinai-2023
PIPRDA-2023
ICMRS'23
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 8 Issue 5
September-October 2026
Indexing Partners
Mpurities in Pharmaceutical Elemental Impurities in Pharmaceutical Risk Assessment of Products: A Review Products a Review Elemental Impurities in Pharm
| Author(s) | Ms Shahitha Afreen, Ms Shafna Tv, Ms Akhil NP |
|---|---|
| Country | India |
| Abstract | Elemental impurities are trace inorganic substances that may enter pharmaceutical products through Poonthavanam post, Perinthalmanna, Malappuram, Kerala – 679325 active pharmaceutical ingredients, excipients, catalysts, manufacturing equipment, water, environmental exposure, and container-closure systems. Their presence is important because toxicity depends on the specific element, dose, route of administration, and duration of exposure. This review summarizes the major sources and classes of elemental impurities, the principles of toxicological evaluation, and the risk-based approach used to assess and control them in pharmaceutical manufacturing. Particular emphasis is placed on the principles of ICH Q3D, including permitted daily exposures (PDEs), route-specific considerations, source identification, risk estimation, analytical verification, and control strategy. Common analytical techniques such as inductively coupled plasma mass spectrometry (ICP-MS) and inductively coupled plasma optical emission spectrometry (ICP-OES) are discussed. The review also considers the role of pharmaceutical quality risk management in supplier qualification, process control, equipment selection, water quality, packaging assessment, and lifecycle monitoring. A structured risk-assessment framework and literature-comparison format are presented to support practical quality assurance applications. |
| Keywords | Elemental impurities; Risk assessment; ICH Q3D; Permitted daily exposure; Heavy metals; ICP-MS; ICP-OES; Pharmaceutical quality; Quality risk management. |
| Field | Medical / Pharmacy |
| Published In | Volume 8, Issue 5, September-October 2026 |
| Published On | 2026-09-12 |
Share this

E-ISSN 2582-2160
CrossRef DOI prefix of IJFMR is 10.36948/ijfmr
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.
Powered by Sky Research Publication and Journals